Jialiang Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 12
- Ubiquitin and proteasome pathways 5
- Circular RNAs in diseases 4
- Immunology 18
- Immunotherapy and Immune Responses 12
- Immune cells in cancer 6
- Immune Cell Function and Interaction 5
- Co-authors
- Jeremy N. Rich (3 shared papers)Bruce A. Sullenger (2 shared papers)Tianmeng Sun (28 shared papers)Justin D. Lathia (3 shared papers)Anita B. Hjelmeland (1 shared paper)Xiao-Fan Wang (1 shared paper)Rebekah R. White (1 shared paper)Timothy P. Wakeman (1 shared paper)
- Journals
- Biomaterials (5 papers)Biomaterials Science (4 papers)Neuro-Oncology (2 papers)Science Advances (2 papers)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Jialiang Wang
76 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Nuclear Energy and Engineering 18
- Cancer Research 449
- Genetics 253
- Oncology 578
- Biomaterials 274
Countries citing papers authored by Jialiang Wang
This map shows the geographic impact of Jialiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialiang Wang more than expected).
Fields of papers citing papers by Jialiang Wang
This network shows the impact of papers produced by Jialiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialiang Wang. The network helps show where Jialiang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jialiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 490 | |
| 2 | 2021 | 185 | |
| 3 | 2020 | 160 | |
| 4 | A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation Hit paper breakdown → | 2022 | 145 |
| 5 | 2010 | 125 | |
| 6 | 2022 | 92 | |
| 7 | 2012 | 88 | |
| 8 | 2019 | 82 | |
| 9 | 2007 | 81 | |
| 10 | 2008 | 76 | |
| 11 | 2019 | 75 | |
| 12 | 2020 | 70 | |
| 13 | 2020 | 69 | |
| 14 | 2021 | 68 | |
| 15 | 2015 | 64 | |
| 16 | 2016 | 60 | |
| 17 | 2017 | 60 | |
| 18 | 2020 | 53 | |
| 19 | 2019 | 43 | |
| 20 | 2021 | 41 |
About Jialiang Wang
Jialiang Wang is a scholar working on Molecular Biology, Immunology, Biomedical Engineering, Oncology and Biomaterials, having authored 81 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (12 papers), Nanoplatforms for cancer theranostics (9 papers), Immune cells in cancer (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Immune Cell Function and Interaction (5 papers), Ubiquitin and proteasome pathways (5 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Nuclear Energy and Engineering (18 citations), Cancer Research (449 citations), Genetics (253 citations), Oncology (578 citations) and Biomaterials (274 citations). Jialiang Wang has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Jeremy N. Rich, Bruce A. Sullenger, Tianmeng Sun, Justin D. Lathia, Anita B. Hjelmeland, Xiao-Fan Wang, Rebekah R. White, Timothy P. Wakeman, Siqi Ding and Jinping Ou. Their work appears in journals such as Biomaterials, Biomaterials Science, Neuro-Oncology, Science Advances and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.